Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain in Transfiere – European Forum for Science, Technology & Innovation

Events
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.Transfiere

Next Wednesday, February 16, Gate2Brain will be in Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga.

Our CEO, Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the Boosting Zone for being one of the companies that have been awarded the NEOTEC 2021 program of the CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.

February 14, 2022/by noticias
Tags: Biotech, BoostingZone, CasosdeÉxito, Innovation, medicinesbeyondbarriers, NEOTEC, technology, transfiere2022
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/02/Anadir-un-subtitulo.jpg 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-02-14 18:48:372022-02-14 19:08:09Gate2Brain in Transfiere – European Forum for Science, Technology & Innovation
You might also like
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs receive funding from Women TechEU
G2B receives funding to accelerate its transfer to the market and society
Biotech New Frontiers Award 2022Gate2BrainG2B awarded with Biotech New Frontiers 2022
Innovation & Scalability for the new generationsInnovation & Scalability for the new generations
Grit International Female Accelerator!Grit International Female AcceleratorG2B joined the Grit International Female Accelerator
Sometimes drugs need a bigger push to be more effective and reach their final destination:ExpansionThe drug booster to the brain
Sustainability Policies, Innovation, Entrepreneurship and New Production Models.g2bSustainability Policies, Innovation, Entrepreneurship and New Production Models
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
How to transport drugs to the brain to treat pathologies?¿Cómo transportar fármacos al cerebro para tratar patologías?La Vanguardiadoctorat industrialAn industrial doctorate is looking to transport drugs to the brain to treat...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}